StatPearls, LLC

  • Cytopenia
  • Leukemia, Myeloid, Acute
  • Monosomy
  • Myelodysplastic Syndromes
  • Prognosis

Myelodysplastic Syndrome

Myelodysplastic syndrome (MDS) is a diverse collection of hematologic neoplasms characterized as a clonal disorder of hematopoietic stem cells, resulting in dysplasia and ineffective hematopoiesis within the bone marrow. This condition often leads to various degrees of cytopenias, which can manifest as anemia, leukopenia, or thrombocytopenia. Some individuals with MDS may progress to acute myeloid leukemia (AML), further complicating their clinical course. The prognosis for patients with MDS is highly variable and is influenced by factors such as cytogenetic abnormalities and the severity of cytopenias. Specifically, patients exhibiting the 5q chromosomal deletion tend to have a more favorable prognosis compared to those with monosomy 7, necessitating careful monitoring and tailored management strategies. Participants in this course gain a comprehensive understanding of the etiology, presentation, and management strategies for myelodysplastic syndrome. They learn about the International Prognostic Scoring System (IPSS) and its revised version (R-IPSS), which serve as essential tools for risk stratification and treatment planning. Emphasis is placed on the importance of collaboration among an interprofessional team, including hematologists, nurses, and mental health professionals, to optimize patient care. Such teamwork enhances communication, fosters shared decision-making, and ensures a holistic approach to managing the complexities of MDS, ultimately leading to improved patient outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 9 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • includes Online course / module
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left